What is the difference between Duchenne and Becker muscular dystrophy?

What is the difference between Duchenne and Becker muscular dystrophy?

Both Duchenne and Becker muscular dystrophy are caused by mutations in a protein called dystrophin. In Duchenne muscular dystrophy, functioning dystrophin is completely absent in muscle, while in Becker muscular dystrophy, there is some dystrophin present, although not enough for completely normal muscle function.

What is the life expectancy of people with Duchenne and Becker muscular dystrophy?

Patients with BMD usually live at least 30 years. They have a mean age of death in the mid-40s. The principal cause of death in patients with BMD is heart failure from dilated cardiomyopathy.

Can you survive Duchenne muscular dystrophy?

Until recently, children with Duchenne muscular dystrophy (DMD) did not often live beyond their teens. However, improvements in cardiac and respiratory care mean that life expectancy is increasing, with many DMD patients reaching their 30s, and some living into their 40s and 50s.

When does Becker muscular dystrophy start?

A child with Becker MD may start to walk later than most kids do. But the disease rarely causes health problems until a child has muscle weakness in the hips and pelvis. This usually happens when kids are 10–13 years old. Walking problems are usually noticed around age 15–16.

Is Tom sulfaro still alive?

At 49, Tom Sulfaro of Michigan is the longest-living person with DMD, but he has been on a ventilator for many years. Natalie was already familiar with DMD because her brother had it. He was also born with Down syndrome and died at 14.

Why can’t DMD be cured?

There is currently no cure for the disease, and patients with DMD have an average life expectancy of just 26 years old. A mutation in the dystrophin gene, which is important for maintaining muscle fibers, causes DMD. Muscle fibers in people with DMD are highly susceptible to injury and are also unable to regenerate.

How does Duchenne muscular dystrophy affect the body?

Duchenne muscular dystrophy (DMD) affects the muscles, leading to muscle wasting that gets worse over time. DMD occurs primarily in males, though in rare cases may affect females. The symptoms of DMD include progressive weakness and loss (atrophy) of both skeletal and heart muscle.

Is golodirsen FDA approved for Duchenne muscular dystrophy?

FDA-approved indication: December 2019, golodirsen (VYONDYS 53) was approved for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. National Library of Medicine Drug Information Portal

Is gene therapy a treatment for Duchenne muscular dystrophy?

Gene therapy, as a treatment, is in the early stages of study in humans. A small initial study using gene therapy has given some children improved muscle strength, but long term effects are unknown as of 2020. DMD affects about one in 3,500 to 6,000 males at birth. It is the most common type of muscular dystrophy.